Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Long Read Sequencing Market: By Technology, By Product, By Application, By Workflow, By End-user and Geography
Long Read Sequencing Market size was valued at US$ 496.3 million in 2023 and is poised to grow at CAGR of 24.1% from 2024-2030. Long Read Sequencing (LRS) refers to a category of DNA sequencing technologies that can read longer stretches of DNA in a single pass compared to traditional short-read sequencing methods. Unlike short-read sequencing, which typically reads DNA fragments of 100-300 base pairs, long-read sequencing can produce reads that span thousands to hundreds of thousands of base pairs. This capability is particularly valuable for resolving complex genomic regions, structural variations, and assembling whole genomes more accurately.
The market encompasses the commercial landscape surrounding technologies, tools, and services associated with long-read DNA sequencing. Long-read sequencing can provide more accurate and complete genome assemblies and useful for detecting structural variants and repetitive regions, all these factors drive the growth of the market. Ongoing improvements are likely to reduce costs and increase accessibility which is an opportunity for the market. However, long-read sequencing technologies tend to be more expensive compared to short-read sequencing, also these technologies require specialized equipment and expertise which can restrains the market.
Study Period
2024-2030Base Year
2023CAGR
24.1%Largest Market
North-AmericaFastest Growing Market
North-America
Advancements in technology are a key driving factor for the market. For instance, in March 2023, Illumina launched its high-performance Illumina Complete Long Read Prep, Human assay for conducting human whole-genome sequencing. Technological improvements in long-read sequencing, such as enhanced accuracy and reduced costs, have made these technologies more accessible and attractive for various research and clinical applications. For instance, advancements in nanopore sequencing technology have enabled longer reads and faster sequencing times, which boosts the overall efficiency and accuracy of genomic studies.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 496.3 million |
Market CAGR |
24.1% |
By Product |
|
By Technology |
|
By Application |
|
By Workflow |
|
By End User |
|
Download Free Sample Report
Long Read Sequencing is used in a variety of applications including genome assembly, structural variation detection, transcriptome analysis, and personalized medicine. It is particularly useful for studying complex genetic regions and large-scale genomic projects.
Major companies in the Long Read Sequencing market include Pacific Biosciences (PacBio), Oxford Nanopore Technologies, and Illumina. These companies are known for their advanced sequencing platforms and technologies.
Challenges include higher costs, greater technical complexity, and the need for specialized equipment and expertise. Additionally, data analysis for long reads can be more complex compared to short reads.
While North America remains the leading market, regions such as Asia-Pacific are experiencing rapid growth due to increased investments in biotechnology, healthcare advancements, and research activities.While North America remains the leading market, regions such as Asia-Pacific are experiencing rapid growth due to increased investments in biotechnology, healthcare advancements, and research activities.
1.Executive Summary |
2.Global Long Read Sequencing Market Introduction |
2.1.Global Long Read Sequencing Market - Taxonomy |
2.2.Global Long Read Sequencing Market - Definitions |
2.2.1.Product |
2.2.2.Technology |
2.2.3.Application |
2.2.4.Workflow |
2.2.5.End-user |
2.2.6.Region |
3.Global Long Read Sequencing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Long Read Sequencing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Long Read Sequencing Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Instruments |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Consumables |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Services |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Long Read Sequencing Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Single-Molecule Real- Time Sequencing |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Nanopore Sequencing |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Synthetic Long Read Sequencing |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Long Read Sequencing Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Whole Genome Sequencing |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Epigenetics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. RNA Sequencing |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Complex Population |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Targeted Sequencing |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Others |
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
8.Global Long Read Sequencing Market By Workflow, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Pre-Sequencing |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Sequencing |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Data Analysis |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9.Global Long Read Sequencing Market By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Academic and Research Institutes |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Clinical Laboratories |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Hospitals |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Pharma and Biotech Entities |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Others |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.Global Long Read Sequencing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. North America |
10.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
10.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.1.3. Market Opportunity Analysis |
10.2. Europe |
10.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
10.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.2.3. Market Opportunity Analysis |
10.3. Asia Pacific (APAC) |
10.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
10.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.3.3. Market Opportunity Analysis |
10.4. Middle East and Africa (MEA) |
10.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
10.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.4.3. Market Opportunity Analysis |
10.5. Latin America |
10.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
10.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.5.3. Market Opportunity Analysis |
11.North America Long Read Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Instruments |
11.1.2.Consumables |
11.1.3.Services |
11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Single-Molecule Real- Time Sequencing |
11.2.2.Nanopore Sequencing |
11.2.3.Synthetic Long Read Sequencing |
11.2.4.Others |
11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Whole Genome Sequencing |
11.3.2.Epigenetics |
11.3.3.RNA Sequencing |
11.3.4.Complex Population |
11.3.5.Targeted Sequencing |
11.3.6.Others |
11.4. Workflow Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Pre-Sequencing |
11.4.2.Sequencing |
11.4.3.Data Analysis |
11.5. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Academic and Research Institutes |
11.5.2.Clinical Laboratories |
11.5.3.Hospitals |
11.5.4.Pharma and Biotech Entities |
11.5.5.Others |
11.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.6.1.United States of America (USA) |
11.6.2.Canada |
12.Europe Long Read Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Instruments |
12.1.2.Consumables |
12.1.3.Services |
12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Single-Molecule Real- Time Sequencing |
12.2.2.Nanopore Sequencing |
12.2.3.Synthetic Long Read Sequencing |
12.2.4.Others |
12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Whole Genome Sequencing |
12.3.2.Epigenetics |
12.3.3.RNA Sequencing |
12.3.4.Complex Population |
12.3.5.Targeted Sequencing |
12.3.6.Others |
12.4. Workflow Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Pre-Sequencing |
12.4.2.Sequencing |
12.4.3.Data Analysis |
12.5. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.Academic and Research Institutes |
12.5.2.Clinical Laboratories |
12.5.3.Hospitals |
12.5.4.Pharma and Biotech Entities |
12.5.5.Others |
12.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.6.1.Germany |
12.6.2.France |
12.6.3.Italy |
12.6.4.United Kingdom (UK) |
12.6.6.Spain |
13.Asia Pacific (APAC) Long Read Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Instruments |
13.1.2.Consumables |
13.1.3.Services |
13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Single-Molecule Real- Time Sequencing |
13.2.2.Nanopore Sequencing |
13.2.3.Synthetic Long Read Sequencing |
13.2.4.Others |
13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Whole Genome Sequencing |
13.3.2.Epigenetics |
13.3.3.RNA Sequencing |
13.3.4.Complex Population |
13.3.5.Targeted Sequencing |
13.3.6.Others |
13.4. Workflow Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Pre-Sequencing |
13.4.2.Sequencing |
13.4.3.Data Analysis |
13.5. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.Academic and Research Institutes |
13.5.2.Clinical Laboratories |
13.5.3.Hospitals |
13.5.4.Pharma and Biotech Entities |
13.5.5.Others |
13.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.6.1.China |
13.6.2.India |
13.6.3.Australia and New Zealand (ANZ) |
13.6.4.Japan |
13.6.6.Rest of APAC |
14.Middle East and Africa (MEA) Long Read Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Instruments |
14.1.2.Consumables |
14.1.3.Services |
14.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Single-Molecule Real- Time Sequencing |
14.2.2.Nanopore Sequencing |
14.2.3.Synthetic Long Read Sequencing |
14.2.4.Others |
14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Whole Genome Sequencing |
14.3.2.Epigenetics |
14.3.3.RNA Sequencing |
14.3.4.Complex Population |
14.3.5.Targeted Sequencing |
14.3.6.Others |
14.4. Workflow Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Pre-Sequencing |
14.4.2.Sequencing |
14.4.3.Data Analysis |
14.5. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Academic and Research Institutes |
14.5.2.Clinical Laboratories |
14.5.3.Hospitals |
14.5.4.Pharma and Biotech Entities |
14.5.5.Others |
14.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.6.1.GCC Countries |
14.6.2.South Africa |
14.6.3.Rest of MEA |
15.Latin America Long Read Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
15.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.1.1.Instruments |
15.1.2.Consumables |
15.1.3.Services |
15.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.2.1.Single-Molecule Real- Time Sequencing |
15.2.2.Nanopore Sequencing |
15.2.3.Synthetic Long Read Sequencing |
15.2.4.Others |
15.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.3.1.Whole Genome Sequencing |
15.3.2.Epigenetics |
15.3.3.RNA Sequencing |
15.3.4.Complex Population |
15.3.5.Targeted Sequencing |
15.3.6.Others |
15.4. Workflow Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.4.1.Pre-Sequencing |
15.4.2.Sequencing |
15.4.3.Data Analysis |
15.5. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.5.1.Academic and Research Institutes |
15.5.2.Clinical Laboratories |
15.5.3.Hospitals |
15.5.4.Pharma and Biotech Entities |
15.5.5.Others |
15.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15.6.1.Brazil |
15.6.2.Mexico |
15.6.3.Rest of LA |
16. Competition Landscape |
16.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
16.2.1.Illumina, Inc. (U.S.) |
16.2.2.MicrobesNG (U.S.) |
16.2.3.Roche Sequencing (U.S.) |
16.2.4.F. Hoffmann-La Roche Ltd. (Switzerland) |
16.2.5.PacBio (U.S.) |
16.2.6.Oxford Nanopore Technologies plc (U.K.) |
16.2.7.Quantapore, Inc.(U.S.) |
16.2.8.FG Technologies (Switzerland) |
16.2.9.BaseClearB.V (Netherlands) |
17. Research Methodology |
18. Appendix and Abbreviations |
Key Market Players